Establishment Labs Holdings Inc. (ESTA)

NASDAQ: ESTA · IEX Real-Time Price · USD
50.89
+0.13 (0.25%)
Mar 28, 2024, 3:19 PM EDT - Market open
0.25%
Market Cap 1.38B
Revenue (ttm) 165.15M
Net Income (ttm) -78.50M
Shares Out 27.21M
EPS (ttm) -3.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 219,112
Open 50.99
Previous Close 50.76
Day's Range 50.54 - 51.63
52-Week Range 16.96 - 79.88
Beta 1.23
Analysts Strong Buy
Price Target 63.43 (+24.65%)
Earnings Date May 6, 2024

About ESTA

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Jul 19, 2018
Employees 908
Stock Exchange NASDAQ
Ticker Symbol ESTA
Full Company Profile

Financial Performance

In 2023, ESTA's revenue was $165.15 million, an increase of 2.13% compared to the previous year's $161.70 million. Losses were -$78.50 million, 4.38% more than in 2022.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for ESTA stock is "Strong Buy." The 12-month stock price forecast is $63.43, which is an increase of 24.65% from the latest price.

Price Target
$63.43
(24.65% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

4 weeks ago - Business Wire

Establishment Labs Announces Participation in Two Upcoming Investment Conferences

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

4 weeks ago - Business Wire

Establishment Labs Announces Amended Credit Facility with Oaktree

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, today ...

5 weeks ago - Business Wire

Establishment Labs to Announce Fourth Quarter 2023 Financial Results on February 28

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

6 weeks ago - Business Wire

Establishment Labs Announces Commercial Launch of Motiva Implants in China

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

2 months ago - Business Wire

Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA) (“Establishment Labs” or the “Company”), a global medical technology company dedicated to improving women's health and wellne...

2 months ago - Business Wire

Establishment Labs Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

3 months ago - Business Wire

Establishment Labs to Present at the 42nd Annual J.P. Morgan Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

3 months ago - Business Wire

Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

5 months ago - Business Wire

Establishment Labs Reports Third Quarter 2023 Financial Results

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

5 months ago - Business Wire

Establishment Labs to Announce Third Quarter 2023 Financial Results on November 7

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

5 months ago - Business Wire

Establishment Labs Announces FDA Clearance of Motiva Flora SmoothSilk Tissue Expander

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

5 months ago - Business Wire

Establishment Labs Announces Two-Year Mia Femtech Clinical Results and the Launch of Zen at 8th World Symposium on Ergonomic Implants

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

5 months ago - Business Wire

Establishment Labs Reports Record Second Quarter 2023 Financial Results

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

8 months ago - Business Wire

Establishment Labs to Announce Second Quarter 2023 Financial Results on August 8

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

8 months ago - Business Wire

Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded Capabilities

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

9 months ago - Business Wire

Establishment Labs to Participate in Two Upcoming Investor Conferences

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

10 months ago - Business Wire

Establishment Labs Announces CE Mark Approval for Minimally Invasive Surgical Tools

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

10 months ago - Business Wire

Establishment Labs Reports Record First Quarter 2023 Financial Results

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

11 months ago - Business Wire

Establishment Labs Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters' Option to Purchase Additional Shares

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a global medical technology company dedicated to improving women's health and wellness, principally in breas...

1 year ago - Business Wire

Establishment Labs to Announce First Quarter 2023 Financial Results on May 8

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

1 year ago - Business Wire

Establishment Labs Announces Pricing of Public Offering of Common Shares

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA) (the “Company”), a global medical technology company dedicated to improving women's health and wellness, principally in breas...

1 year ago - Business Wire

Establishment Labs Announces Proposed Public Offering of Common Shares

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA) (the “Company”), a global medical technology company dedicated to improving women's health and wellness, principally in breas...

1 year ago - Business Wire

Establishment Labs Announces Preliminary Unaudited Results for First Quarter 2023

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA) (the “Company”), a global medical technology company dedicated to improving women's health and wellness, principally in breas...

1 year ago - Business Wire

Establishment Labs Notes Presentation of 3-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2023

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

1 year ago - Business Wire